Savara (SVRA) Return on Sales (2013 - 2022)
Savara (SVRA) reported Return on Sales of 413.68% for Q1 2022, down 24195.75% on a QoQ basis from 1.7% in Q4 2021.
Savara (SVRA) has 8 years of Return on Sales data on file, last reported at 413.68% in Q1 2022.
- Quarterly Return on Sales changed N/A year-over-year to 413.68% in Q1 2022, while the trailing twelve-month figure through Mar 2022 was 413.68% (changed N/A YoY) and the FY2020 annual result came in at 1.98%, changed N/A from the prior year.
- Return on Sales fell to 413.68% in Q1 2022 per SVRA's latest filing, from 1.7% in the prior quarter.
- Across five years, Return on Sales topped out at 0.44% in Q3 2020 and bottomed at 413.68% in Q1 2022.
- The 3-year median for Return on Sales is 1.79% (2021), against an average of 110.61%.
- Peak annual rise in Return on Sales reached 13372 bps in 2021, while the deepest fall reached 135 bps in 2021.
- Tracing SVRA's Return on Sales over 3 years: stood at 135.42% in 2020, then soared by 99 bps to 1.7% in 2021, then tumbled by 24196 bps to 413.68% in 2022.
- Per Business Quant, the three latest SVRA Return on Sales figures stand at 413.68% (Q1 2022), 1.7% (Q4 2021), and 1.79% (Q3 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.00% |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -413.68% |
| Dec 31, 2021 | -1.70% |
| Sep 30, 2021 | -1.79% |
| Dec 31, 2020 | -135.42% |
| Sep 30, 2020 | -0.44% |
| Sep 30, 2017 | -0.65% |
| Jun 30, 2017 | 1.22% |
| Mar 31, 2017 | -0.53% |
| Dec 31, 2016 | -0.07% |
| Sep 30, 2016 | -0.72% |
| Jun 30, 2016 | -4.87% |
| Mar 31, 2016 | -6.37% |
| Dec 31, 2015 | -2.25% |
| Mar 31, 2014 | -0.45% |
| Dec 31, 2013 | -0.24% |
| Jun 30, 2013 | -0.10% |
| Mar 31, 2013 | -0.14% |